He leads oncology and hematology studies across multiple sites globally (Americas, Europe, and Asia Pacific) and mentors new Clinical Operations Leads.
LONDON, ONTARIO, CANADA, September 19, 2023 /24-7PressRelease/ — Navneet Singh has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Mr. Singh is an accomplished management professional with years of experience in all aspects of clinical research including site monitoring, trial operations, and site, project, and vendor management. Mr. Singh presently excels as the Global Senior Clinical Operations Leader for Parexel International. In this capacity, he leads oncology and hematology studies across multiple sites globally (Americas, Europe, and Asia Pacific) and mentors new Clinical Operations Leads. Prior to obtaining his current role, Mr. Singh worked for the company as a Clinical Operations Leader, and served in Clinical Project Management roles with Innovaderm Research Inc. and Alimentiv (formerly known as Robarts Clinical Trials).
Over the years, Mr. Singh honed his experience in CRO management, logistics, and the execution of clinical trials (pre- and post-market) from inception to publication in the areas of cardiology, oncology, hematology, pulmonology, endocrinology, dermatology, nephrology, neuroscience, gastroenterology, vaccines, and the peripheral vascular system. He worked in management for the Asia Pacific, Middle East, and African regions for Boston Scientific. During the early stages of his career, Mr. Singh gained valuable expertise in various aspects of the industry through educational, research, and leadership positions with Clinogent, Abbott Vascular, LG Life Sciences, Eli Lilly and Company, Delhi University, and the H.N.B Garhwal Central University.
An expert in his field, Mr. Singh holds a Bachelor of Science (H) and Master of Science in Biomedical Sciences from Delhi University, and a Certificate of Excellence in Executive Leadership from Rotman School of Management (University of Toronto). Subsequently, he expanded upon his professional knowledge by earning certifications in Executive Strategy Programme from Saïd Business School (University of Oxford) and completing a Pro Immuonology – Immuno-oncology course through Harvard Medical School.
He also has elite qualifications namely Project Management Professional (PMP) from Project Management Institute (PMI), PRINCE 2 Registered Practitioner from Axelos, a Six Sigma Green Belt from Eli Lilly and Company, BioReady Professional (Clinical Trial Project Manager) from BioTalent Canada, Council of Scientific and Industrial Research – University Grants Commission – National Eligibility Test (CSIR UGC – NET) in Life Sciences, Lead Auditor for Quality Management System (QMS) in ISO 9001 from Lloyd’s Register Quality Assurance (LRQA), ISO 14155 for Medical Devices through Abbott Vascular, Advanced ICH-GCP for Experts in Clinical Research from Vienna School of Clinical Research, Teaching English to Speaker of Other Languages (TESOL) from International Open Academy and various certifications through the Association of Clinical Research Professionals (ACRP) namely Certified Professional (CP), Project Manager (PM) and Medical Device Professional (MDP).
In light of his professional achievements, Mr. Singh has been honored many times. More recently he was honored for his Clinical Trial Management skills through PhamaTimes where he was finalist for Clinical Researcher of the Year for Americas 2022 under Clinical Trial Manager category. He has been conferred the Power to Win (PTW) Awards from Boston Scientific i.e., Overall Best Performer in Clinical Affairs and Star Award for contribution in Asia Pacific Middle East and Africa (AMEA). He has earned an Employee of the Month Award, the Catch Me At My Best Award from Eli Lilly and Company, and an Outstanding Achiever Award through Clinogent. He was also a finalist at university level by participating in Science Aptitude Contests in the Life Sciences category. Due to his vast breadth of knowledge, Mr. Singh has also spoken at a national symposium titled “Recent Advances in Science: A Prospective” where he talked about “Effect of chronic administration of ethanol and fats on the prognosis of alcoholic liver disease.”
While his career has been filled with highlights, Mr. Singh takes the most pride in his current work with Parexel where he is managing global studies, and pursuing continued education. The cornerstone of his success lay in his passion for what he does. Looking ahead, Mr. Singh aims to pursue his study of the French language and experience the continued growth and success of his career.
About Marquis Who’s Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who’s Who in America®, Marquis Who’s Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who’s Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians, and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who’s Who® website at www.marquiswhoswho.com.
# # #